MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025)

MDxHealth (MDXH) posted Non-Current Deferred Tax Liability of $1.6 million for Q4 2025, down 99.9% sequentially from $1.6 billion in Q2 2025.

MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

MDxHealth has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $1.6 million in Q4 2025.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability retreated to $1.6 million in Q4 2025 per MDXH's latest filing, from $1.6 billion in the prior quarter.
Over five years, Non-Current Deferred Tax Liability peaked at $1.6 billion in Q2 2025 and troughed at $129000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	MDxHealth	36.03 Mn	15.62 Mn	17.89 Mn

Download Data